Approval or no approval. Market does not care for NUVARING any more. Market has also written off this mob and has no hope from them ALREADY
AS market has not even sneezed over this disclosure.
Also means all this WAS ALREADY PRICED IN BY THE MARKET
as market knows it ALL IN ADVANCE....... WINK WINK WINK
- Forums
- ASX - By Stock
- MYX
- Ann: MAYNE PHARMA provides FDA update on generic NUVARING
MYX
mayne pharma group limited
Add to My Watchlist
1.00%
!
$5.07

Ann: MAYNE PHARMA provides FDA update on generic NUVARING, page-18
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.07 |
Change
0.050(1.00%) |
Mkt cap ! $411.9M |
Open | High | Low | Value | Volume |
$5.00 | $5.14 | $4.94 | $712.4K | 141.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1059 | $5.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.13 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1059 | 5.070 |
3 | 4888 | 5.050 |
2 | 3150 | 5.040 |
2 | 1660 | 5.030 |
1 | 1060 | 5.020 |
Price($) | Vol. | No. |
---|---|---|
5.130 | 1000 | 1 |
5.140 | 215 | 1 |
5.150 | 10000 | 1 |
5.160 | 2000 | 1 |
5.170 | 1060 | 1 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online